Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Is the Propel Funeral Partners Ltd (ASX:PFP) share price a takeover target?

After the recent private equity takeover of funeral home operator InvoCare Limited (ASX: IVC) the team at Stock Doctor takes a closer look at the industry’s second-largest player – Propel Funeral Partners Ltd (ASX: PFP).

PFP share price

What is Propel?

Propel Funeral Partners own funeral homes, cemeteries, crematoria and related assets across Australia and New Zealand, providing a broad range of services and products across the death care industry.

The industry is highly fragmented, and benefits from economies of scale which makes it ripe for further consolidation. Hence, we see a continued pathway of consolidation for PFP.

Source: Company presentation

Why the Propel share price is worth a second look

Since its ASX listing in August 2013, Propel has grown from operating one funeral home to ~150 locations.

Source: Company presentation

Propel’s revenue is driven primarily by death volumes, which have increased and begun to grow above historical trends. This may be due to changing demographics including an overall aging of our national population. 

Long term, the Australian Bureau of Statistics (ABS) forecasts volumes to structurally increase over the next decade due to these demographic shifts.

Source: Company presentation

Aside from favourable organic growth trends, the business has executed on a pipeline of mergers and acquisitions (M&A) in CY23, which Propel will look to bed down over the near term.

As the company continues to scale, this could translate to higher profitability metrics such as return on equity (ROE) and net profit margins, as cost synergies are realised. 

ASX investors however need to be cautious of Propel’s rising debt levels, which could place pressure on the company’s balance sheet given the increase in interest rates.

Is the Propel share price undervalued?

With InvoCare being taken off the boards, we think is likely that Propel will attract increasing investor interest. 

The company operates in a defensive industry that typically is not sensitive to economic fluctuations. The growth tailwinds mentioned above make it a compelling emerging opportunity for investors who believe its ~23x forward P/E multiple looks attractive. 

Propel’s share price is currently trading at a discount to consensus valuations… but we know that valuations can be sensitive to changes in forecast assumptions, so perhaps take this with a grain of salt.

Source: Stockdoctor

For our team, Propel’s shares are too illiquid for us to make a meaningful investment at present, but we are keeping a close eye on it due to the improving fundamentals.

Our team at Stock Doctor have been providing bottom-up, high-quality equity research to self-directed Australian investors for decades and we’re offering you FREE access to our platform for 14 days.

We are currently in the trenches of reporting season and will be providing tons of content for those investors who are struggling to find opportunities in this market.

Finally, for those who like the personal touch… any RASK Media reader who creates a free trial (see below) this reporting season will get direct access to our equity research team.

In other words, get a free account and you can chat directly with me about these companies! I’d love to hear from you and talk about our detailed ASX valuation research. 

Get a FREE account simply by clicking HERE or the button below. 

Complimentary Stock Doctor membership – Lincoln Indicators

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.


At the time of publishing, the author or their clients may have a financial interest in some of companies or securities mentioned.

Powered by

Skip to content